Normal Pressure Hydrocephalus: A Diagnostic Challenge in Reversible Dementia

Dr Neeraj Manikath , claude.ai

The Clinical Imperative

Normal pressure hydrocephalus (NPH) stands as a neurological paradox and therapeutic opportunity—a potentially reversible cause of dementia in an era where most neurodegenerative conditions remain intractable. First described by Hakim and Adams in 1965, NPH represents one of the few treatable dementias, yet it remains underdiagnosed, with estimates suggesting only 20% of cases are properly identified. The stakes are considerable: early recognition and appropriate shunting can transform a patient's trajectory from progressive disability to meaningful functional recovery, while delayed diagnosis condemns patients to irreversible decline.

The Pathophysiological Foundation

NPH occurs when cerebrospinal fluid (CSF) accumulation leads to ventricular enlargement despite normal or intermittently elevated intracranial pressure. The underlying mechanism involves impaired CSF absorption at the arachnoid granulations, though production remains normal. This creates a pressure gradient that damages periventricular white matter tracts, particularly affecting frontal-subcortical circuits responsible for executive function, motor planning, and bladder control.

The idiopathic form (iNPH) typically affects adults over 60 years, while secondary NPH follows subarachnoid hemorrhage, meningitis, or traumatic brain injury. Understanding this distinction matters: secondary NPH patients often respond better to shunting and present with clearer temporal relationships between inciting events and symptom onset.

The Classic Triad: Recognizing the Signature

The diagnostic cornerstone remains Hakim's triad, though the sequence and severity vary considerably:

1. Gait Disturbance: The Most Specific Feature

Gait abnormality typically manifests first and responds best to treatment. The characteristic pattern—often termed "magnetic" or "apraxic"—includes:

Wide-based stance with shortened stride length
Foot shuffling with feet appearing "stuck to the floor"
Difficulty initiating gait despite preserved leg strength
Preserved upper body mobility (arms swing normally)
Turning en bloc requiring multiple small steps

Pearl: The gait in NPH differs fundamentally from Parkinson's disease. NPH patients demonstrate better gait with external cues (following footsteps on the floor), whereas Parkinsonian gait involves rigidity, reduced arm swing, and festination. Ask the patient to walk while counting backward—NPH gait typically worsens with dual-tasking, reflecting frontal dysfunction.

Oyster: Falls occur in 40-60% of NPH patients, often resulting in hip fractures or head trauma. Document fall history meticulously—it strengthens the case for intervention and provides baseline data for post-shunt assessment.

2. Cognitive Impairment: The Frontal-Subcortical Pattern

Cognitive decline in NPH follows a distinctive frontal-subcortical pattern:

Psychomotor slowing (bradyphrenia)
Executive dysfunction (impaired planning, set-shifting)
Apathy and reduced spontaneity (often mistaken for depression)
Impaired attention and working memory
Relative preservation of memory encoding (unlike Alzheimer's disease)

Hack: Use the Montreal Cognitive Assessment (MoCA) rather than Mini-Mental State Examination (MMSE). The MoCA better captures frontal-executive deficits through trail-making, clock-drawing, and abstraction tasks. A typical NPH profile shows disproportionate impairment in executive items with preserved orientation and recall.

Pearl: Family members often describe personality change: "He just sits there," or "She doesn't care about anything anymore." This apathy—distinct from depression's dysphoria—reflects dorsolateral prefrontal circuit disruption and should raise NPH suspicion.

3. Urinary Incontinence: The Last Element

Urinary symptoms progress through stages:

Early: Increased frequency and urgency
Middle: Urge incontinence
Late: Complete indifference to incontinence

Oyster: Unlike most incontinence, NPH patients often lack awareness or concern about their bladder dysfunction—another manifestation of frontal lobe impairment. This "frontal incontinence" helps distinguish NPH from urological causes.

Important caveat: The complete triad appears in only 50-75% of cases at presentation. Gait disturbance alone occurs in 95% of surgical candidates, making it the most sensitive feature. Never dismiss NPH based on incomplete triad presentation.

Neuroimaging: Identifying the Anatomical Substrate

MRI: The Gold Standard

Brain MRI provides essential diagnostic information:

Ventriculomegaly Assessment:

Evans Index (ratio of maximal frontal horn width to maximal internal skull diameter) >0.3 indicates ventriculomegaly
Measure at the level of the foramen of Monro on axial images
Values >0.35 strengthen the diagnosis

Disproportionately Enlarged Subarachnoid Space Hydrocephalus (DESH):

Enlarged ventricles with tight high-convexity sulci
Dilated Sylvian fissures
This pattern distinguishes NPH from ex-vacuo ventriculomegaly (brain atrophy)

Hack: Use the "callosal angle" measured on coronal images at the posterior commissure. Angles <90 degrees suggest NPH (normal >100 degrees). This simple measurement improves diagnostic accuracy.

Transependymal CSF Flow:

Periventricular T2/FLAIR hyperintensity
Indicates CSF transudation through ependyma
Present in 75-85% of shunt-responsive patients

Pearl: Order MRI with thin-slice sagittal sequences to assess the aqueduct and third ventricle floor. Look for downward bowing of the corpus callosum and upward bowing of the third ventricle floor—both indicate chronic hydrocephalic pressure.

CT: When MRI is Contraindicated

Non-contrast head CT can demonstrate ventriculomegaly and calculate Evans Index, though it misses subtle white matter changes and provides inferior soft tissue resolution. Reserve CT for patients with pacemakers, severe claustrophobia, or urgent evaluation needs.

The Diagnostic Tap Test: Functional Confirmation

The lumbar puncture (LP) with large-volume CSF removal serves dual purposes: confirming communicating hydrocephalus and predicting shunt responsiveness.

Technique:

Measure opening pressure (typically 5-18 cm H₂O—hence "normal pressure")
Remove 30-50 mL CSF slowly
Send CSF for cell count, protein, glucose to exclude inflammatory/infectious causes

Assessment Protocol:

Baseline: Perform timed 10-meter walk test (record steps and seconds) and cognitive testing
Post-tap: Repeat assessments at 2-4 hours and 24 hours
Positive response: ≥20% improvement in gait speed or ≥20% reduction in steps

Oyster: The tap test has 85-95% positive predictive value but only 25-60% sensitivity. A negative test doesn't exclude NPH—consider extended lumbar drainage (3-5 days of continuous CSF drainage via lumbar catheter) in high-suspicion cases with negative tap tests.

Hack: Video record the patient walking before and after the tap test. This provides objective documentation, facilitates comparison, and proves invaluable when discussing shunting decisions with neurosurgery and families.

Pearl: Beyond gait, assess cognitive speed. Give the patient a simple task (counting backward from 100 by 7s, or serial 3s for less educated patients) before and after tapping. Improvement in processing speed can be dramatic and helps predict cognitive benefits from shunting.

Shunt Surgery: Expected Outcomes and Patient Selection

Ventriculoperitoneal (VP) shunting remains the definitive treatment, with programmable pressure valves allowing postoperative adjustment.

Response Hierarchy:

Gait: Improves in 70-90% of appropriately selected patients—typically the most dramatic and earliest improvement
Urinary incontinence: Improves in 50-80%—may take weeks to months
Cognition: Improves in 40-70%—often modest and limited by coexisting pathology

Pearl: Set realistic expectations with patients and families. Frame cognitive improvement cautiously: "We hope to stop the decline and may see some improvement, but our best target is walking and bladder control." This prevents disappointment when cognitive recovery is incomplete.

Prognostic Factors:

Good Prognosis:

Short symptom duration (<2 years)
Gait disturbance as first symptom
Clear positive tap test
Absence of significant white matter disease
Secondary NPH (post-SAH, post-meningitis)

Poor Prognosis:

Long symptom duration (>3 years)
Dementia predominating
Significant comorbid pathology (strokes, advanced small vessel disease)
Negative tap test

Complications:

Shunt surgery carries 5-10% serious complication rates:

Subdural hematoma (most common—occurs in elderly patients with brain atrophy)
Shunt infection (1-5%)
Shunt malfunction requiring revision (30-40% over 5 years)
Over-drainage headaches

Hack: When subdural hematoma occurs post-shunt, it often reflects overdrainage. Adjust programmable valve to higher pressures rather than rushing to surgical evacuation—many resolve with conservative management.

Differential Diagnosis: Avoiding Mimics

Alzheimer's Disease

Memory impairment predominates (encoding deficit)
Hippocampal atrophy on MRI
Typical gait late in disease
Proportionate ventriculomegaly to cortical atrophy

Vascular Dementia

Stepwise progression
Cortical/subcortical infarcts on imaging
Extensive white matter disease (Fazekas grade 3)
Risk factors: hypertension, diabetes, atrial fibrillation

Pearl: NPH and vascular dementia frequently coexist. Don't let white matter hyperintensities dissuade you—if ventriculomegaly seems disproportionate and gait disturbance is prominent, proceed with tap test. Some patients have "mixed" pathology but still benefit from shunting.

Parkinson's Disease

Resting tremor, rigidity, bradykinesia
Asymmetric onset
Response to levodopa
Normal ventricular size

Oyster: Some Parkinson's patients develop ventriculomegaly from atrophy. The key distinguisher: NPH gait lacks the rigidity and reduced arm swing of parkinsonism. When doubt exists, a tap test showing dramatic gait improvement strongly suggests NPH.

Progressive Supranuclear Palsy (PSP)

Early falls (within first year)
Vertical gaze palsy (especially downgaze)
Axial rigidity predominating
Midbrain atrophy ("hummingbird sign" on MRI)

Clinical Pearls: Expert Insights

Screening Pearl: Any patient over 60 with unexplained gait disorder deserves brain imaging to evaluate for NPH. The yield is high enough to justify liberal screening.

Timing Pearl: Intervene early. Every month of delay allows further white matter damage. Once a patient is bedridden or severely demented, shunt success rates plummet.

Follow-up Pearl: Post-shunt patients need regular monitoring. Improvement may plateau at 3-6 months. If decline occurs after initial improvement, suspect shunt malfunction—promptly obtain shunt series radiographs and neurosurgical consultation.

Documentation Pearl: Quantify everything. Use timed walks, standardized cognitive tests, and validated scales (NPH scale, iNPH Grading Scale). Objective measures strengthen the case for intervention and track outcomes.

Emerging Concepts and Future Directions

Recent research expands our understanding:

MRI Biomarkers: CSF flow void at the aqueduct on T2-weighted imaging (hyperdynamic flow) predicts shunt response. Diffusion tensor imaging showing decreased fractional anisotropy in periventricular white matter correlates with NPH severity.

Clinical Subtypes: Some experts propose subdividing iNPH into "gait-predominant" and "cognitive-predominant" phenotypes, with differing prognoses and optimal timing for intervention.

Alternative Drainage: Lumboperitoneal shunting offers an option when VP shunting fails or is contraindicated, though long-term outcomes appear slightly inferior.

Conclusion: The Clinical Mandate

Normal pressure hydrocephalus represents a diagnostic and therapeutic opportunity that demands vigilance. In an aging population burdened by dementia, NPH offers the rare possibility of meaningful reversal. The complete triad occurs inconsistently, imaging findings require careful interpretation, and the tap test has imperfect sensitivity—yet these challenges must not deter evaluation of appropriate candidates.

The bottom line: Any elderly patient with unexplained gait disturbance, particularly when accompanied by cognitive decline or urinary symptoms, deserves systematic NPH evaluation. The cost of missing this diagnosis—progressive disability from a treatable condition—far exceeds the modest investment in imaging and diagnostic testing. Early recognition transforms lives; delayed diagnosis perpetuates preventable suffering.

As educators and clinicians, our responsibility extends beyond treating the patients before us to teaching the next generation to maintain appropriate diagnostic suspicion for this reversible cause of dementia. Normal pressure hydrocephalus reminds us that careful clinical observation, thoughtful imaging interpretation, and willingness to pursue definitive testing can still alter disease trajectories in modern medicine.

Selected References

Hakim S, Adams RD. The special clinical problem of symptomatic hydrocephalus with normal cerebrospinal fluid pressure. Observations on cerebrospinal fluid hydrodynamics. J Neurol Sci. 1965;2(4):307-327.
Relkin N, Marmarou A, Klinge P, et al. Diagnosing idiopathic normal-pressure hydrocephalus. Neurosurgery. 2005;57(3 Suppl):S4-16.
Mori E, Ishikawa M, Kato T, et al. Guidelines for management of idiopathic normal pressure hydrocephalus: second edition. Neurol Med Chir (Tokyo). 2012;52(11):775-809.
Jaraj D, Rabiei K, Marlow T, et al. Prevalence of idiopathic normal-pressure hydrocephalus. Neurology. 2014;82(16):1449-1454.
Espay AJ, Da Prat GA, Dwivedi AK, et al. Deconstructing normal pressure hydrocephalus: Ventriculomegaly as early sign of neurodegeneration. Ann Neurol. 2017;82(4):503-513.
Marmarou A, Young HF, Aygok GA, et al. Diagnosis and management of idiopathic normal-pressure hydrocephalus: a prospective study in 151 patients. J Neurosurg. 2005;102(6):987-997.
Ringstad G, Vatnehol SAS, Eide PK. Glymphatic MRI in idiopathic normal pressure hydrocephalus. Brain. 2017;140(10):2691-2705.
Toma AK, Papadopoulos MC, Stapleton S, et al. Systematic review of the outcome of shunt surgery in idiopathic normal-pressure hydrocephalus. Acta Neurochir (Wien). 2013;155(10):1977-1980.

Search This Blog

Internal medicine